APELLIS PHARMACT.DL-0001
Healthcare · EUR · F
Price
€34.049
Cap
€5.25B
Earnings
—
30d Trend
+0.8%
439% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 38×Macro 0.99 (−1%)=38
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 64 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
5-10 day swing — oversold bounce candidate
BRAIN47'S ASSESSMENT
I rate APELLIS PHARMACT.DL-0001 at 38/100 — a WEAK reading on the Brain47 Signal. The strongest factor is quality at 69/100. I classify this as a speculative position with the strongest thesis on a short-term horizon.
PAST PERFORMANCE
1 MONTH
-91.8%
3 MONTHS
-83.9%
12 MONTHS
-80.6%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
5-10 day swing — oversold bounce candidate. Quality (69) and Momentum (45) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 439%. I classify this as a speculative position — elevated volatility at 439% and asymmetric payoff potential define the opportunity.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.